Gene signature discovery may predict response to immune therapy

Understanding how cancer differs between sexes

Novel approach yields four robust biomarkers for breast cancer drug response

OICR’s Dr. Clare Jeon discusses how the discovery of protein signatures could lead to cheaper, easier diagnostic tests for prostate cancer

New research better defines which patients will respond to colorectal cancer drug

Discovery by OICR scientists to assist in personalizing prostate cancer treatment